Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kostyantyn Krysan

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Investigative Ophthalmology & Visual Science|May 31, 2002
Regulation of human thioltransferase (hTTase) gene by AP-1 transcription factor under oxidative stressKostyantyn Krysan, Marjorie F Lou
Cancer Discovery|October 2, 2020
Immunosurveillance and Regression in the Context of Squamous Pulmonary PremalignancyKostyantyn Krysan, Linh M Tran, Steven M Dubinett
Anti-Cancer Agents in Medicinal Chemistry|May 23, 2006
The potential and rationale for COX-2 inhibitors in lung cancerKostyantyn Krysan, Karen L Reckamp, Sherven Sharma, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 29, 2020
Lung Cancer and Immunity MarkersRaymond J Lim, Bin Liu, Kostyantyn Krysan, et al.
Cancer Research|September 18, 2004
Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancerKostyantyn Krysan, Harnisha Dalwadi, Sherven Sharma, et al.
Cancer Research Communications|June 10, 2024
Noninvasive Lung Cancer Subtype Classification Using Tumor-Derived Signatures and cfDNA MethylomeShuo Li, Wenyuan Li, Bin Liu, et al.
Future Oncology (London, England)|March 27, 2007
Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLCJay M Lee, Jenny T Mao, Kostyantyn Krysan, et al.
Cancer Research|February 20, 2003
Abnormal interleukin 10Ralpha expression contributes to the maintenance of elevated cyclooxygenase-2 in non-small cell lung cancer cellsNathalie Heuze-Vourc'h, Li Zhu, Kostyantyn Krysan, et al.
Cancer Research|July 19, 2005
Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent mannerKostyantyn Krysan, Karen L Reckamp, Harnisha Dalwadi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2004
Prostaglandin E2-dependent enhancement of tissue inhibitors of metalloproteinases-1 production limits dendritic cell migration through extracellular matrixFelicita E Baratelli, Nathalie Heuzé-Vourc'h, Kostyantyn Krysan, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Investigative Ophthalmology & Visual Science|May 31, 2002
Regulation of human thioltransferase (hTTase) gene by AP-1 transcription factor under oxidative stressKostyantyn Krysan, Marjorie F Lou
Cancer Discovery|October 2, 2020
Immunosurveillance and Regression in the Context of Squamous Pulmonary PremalignancyKostyantyn Krysan, Linh M Tran, Steven M Dubinett
Anti-Cancer Agents in Medicinal Chemistry|May 23, 2006
The potential and rationale for COX-2 inhibitors in lung cancerKostyantyn Krysan, Karen L Reckamp, Sherven Sharma, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 29, 2020
Lung Cancer and Immunity MarkersRaymond J Lim, Bin Liu, Kostyantyn Krysan, et al.
Cancer Research|September 18, 2004
Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancerKostyantyn Krysan, Harnisha Dalwadi, Sherven Sharma, et al.
Cancer Research Communications|June 10, 2024
Noninvasive Lung Cancer Subtype Classification Using Tumor-Derived Signatures and cfDNA MethylomeShuo Li, Wenyuan Li, Bin Liu, et al.
Future Oncology (London, England)|March 27, 2007
Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLCJay M Lee, Jenny T Mao, Kostyantyn Krysan, et al.
Cancer Research|February 20, 2003
Abnormal interleukin 10Ralpha expression contributes to the maintenance of elevated cyclooxygenase-2 in non-small cell lung cancer cellsNathalie Heuze-Vourc'h, Li Zhu, Kostyantyn Krysan, et al.
Cancer Research|July 19, 2005
Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent mannerKostyantyn Krysan, Karen L Reckamp, Harnisha Dalwadi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2004
Prostaglandin E2-dependent enhancement of tissue inhibitors of metalloproteinases-1 production limits dendritic cell migration through extracellular matrixFelicita E Baratelli, Nathalie Heuzé-Vourc'h, Kostyantyn Krysan, et al.
Pageof 6